AINOS INC

Ainos Inc. reports a 20% revenue rise in Q2 2026, driven by expanding AI Nose tech into semiconductor, industrial, and healthcare markets, boosting profits and cash reserves.

Ainos Inc. is a biotechnology company that has demonstrated resilience and adaptability in the face of market fluctuations, with a focus on developing novel treatments for various diseases and a commitment to improving patient outcomes.

Ainos Inc. has partnered with Kenmec to scale AI-powered scent detection technology, aiming to integrate it into various industrial applications such as robotics, logistics, and manufacturing.